Description

Retatrutide 50mg — High-Volume Metabolic Research Supply

Retatrutide 50mg is the largest available format of Brava’s Retatrutide offering — designed for research labs, extended study timelines, or multi-subject protocols that require a high-volume, single-batch source.

The compound is identical to Brava’s 10mg and 20mg formats: Retatrutide (LY3437943), the GLP-1/GIP/glucagon triple receptor agonist currently in Phase III clinical development by Eli Lilly. The 50mg quantity allows researchers to run complete extended protocols without the inter-batch variability that comes from ordering multiple smaller vials.

At this volume, Retatrutide 50mg is particularly relevant for protocols pairing it with KLOW Blend — the Retatrutide + KLOW combination is one of the most actively researched stacks in the current metabolic and regenerative signaling literature.

Sourced from U.S. cGMP-certified manufacturing facilities. Independent third-party COA included with every order. For research use only. Not for human or veterinary consumption.

Best For: Metabolic; Body Composition

Category: Metabolic

For Research Use Only (RUO). Not for human or veterinary use. Not a drug. Not intended to diagnose, treat, cure, or prevent any disease.